Gary W. Cleary
52Patents
24h-index
34Co-inventors
88Inventor score
Filing activity: Jul 12, 1977 → Feb 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4201211A | Therapeutic system for administering clonidine transdermally | Performing Operations; Transporting | 328 | Expired |
| US4906463A | Transdermal drug-delivery composition | Human Necessities | 191 | Expired |
| US6803420B2 | Two-phase, water-absorbent bioadhesive composition | Chemistry; Metallurgy | 158 | Expired |
| US5006342A | Resilient transdermal drug delivery device | Human Necessities | 150 | Expired |
| US4973468A | Skin permeation enhancer compositions | Human Necessities | 137 | Expired |
| US4915950A | Printed transdermal drug delivery device | Human Necessities | 130 | Expired |
| US7611481B2 | Transdermal delivery device | Human Necessities | 107 | Expired |
| US6576712B2 | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties | Human Necessities | 98 | Expired |
| US5053227A | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith | Human Necessities | 92 | Expired |
| US5271940A | Transdermal delivery device having delayed onset | Human Necessities | 81 | Expired |
| US5217718A | Method and device for administering dexmedetomidine transdermally | Human Necessities | 67 | Expired |
| US5059426A | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith | Human Necessities | 65 | Expired |
| US4911916A | Diffusion matrix for transdermal drug administration and transdermal drug delivery devices including same | Human Necessities | 59 | Expired |
| US5234690A | Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset | Human Necessities | 51 | Expired |
| US7217853B2 | Composition for cushions, wound dressings and other skin-contacting products | Human Necessities | 50 | Expired |
| US7914480B2 | Transdermal delivery device | Human Necessities | 44 | Active |
| US5091186A | Biphasic transdermal drug delivery device | Human Necessities | 44 | Expired |
| US5273756A | Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset | Human Necessities | 44 | Expired |
| US5273755A | Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset | Human Necessities | 42 | Expired |
| US5603947A | Method and device for providing nicotine replacement therapy transdermally/transbuccally | Human Necessities | 38 | Expired |
| US7456331B2 | Composition for cushions, wounds dressings and other skin-contacting products | Human Necessities | 36 | Active |
| US5124157A | Method and device for administering dexmedetomidine transdermally | Human Necessities | 36 | Expired |
| US8481059B2 | Hydrogel compositions | Human Necessities | 34 | Active |
| US7138458B2 | Method for preparing a two-phase water-absorbent bioadhesive composition | Chemistry; Metallurgy | 27 | Expired |
| US5186939A | Laminated composite for transdermal administration of fentanyl | Human Necessities | 24 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.